SCHEMBL6711744

SCHEMBL6711744

COc1ccccc1-c1cccc2cc(C(=O)Nc3ccc(Br)cc3-c3nnn[nH]3)n(C)c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 4/20 0.42
NPSR1 Q6W5P4 5/20 0.39
HIF1A Q16665 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
POLB P06746 4/20 0.38
LMNA P02545 2/20 0.38
MAPT P10636 3/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
KDM4E B2RXH2 2/20 0.38
TP53 P04637 3/20 0.38
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
CYP2D6 P10635 1/20 0.38
ALOX15 P16050 1/20 0.38
HSD17B10 Q99714 1/20 0.38
USP2 O75604 1/20 0.38
BACE1 P56817 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6711785 0.90 HPGD (0.40) HIF1APOLBMAPTKDM4EHSD17B10
SCHEMBL6710507 0.89 HIF1A (0.42) GPR35NPSR1HIF1ARXFP1POLB
SCHEMBL6712008 0.88 HIF1A (0.40) GPR35NPSR1HIF1ARXFP1LMNA
SCHEMBL6710170 0.88 NPSR1 (0.43) GPR35NPSR1HIF1ARXFP1POLB
SCHEMBL6712448 0.88 KDM4E (0.36) LMNAMAPTKDM4EALOX15HSD17B10
SCHEMBL6712280 0.86 NPSR1 (0.36) GPR35NPSR1HIF1ARXFP1POLB
SCHEMBL6709863 0.86 HIF1A (0.38) GPR35NPSR1HIF1ARXFP1LMNA
SCHEMBL6708968 0.86 HIF1A (0.41) GPR35NPSR1HIF1ARXFP1LMNA
SCHEMBL6707800 0.86 NPSR1 (0.37) GPR35NPSR1HIF1ARXFP1LMNA
SCHEMBL6713815 0.85 HIF1A (0.41) GPR35NPSR1HIF1ARXFP1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 GPR35 2928/4885NPSR1 2999/4885HIF1A 296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.